<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01810991</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-1440-BK-HID1</org_study_id>
    <nct_id>NCT01810991</nct_id>
  </id_info>
  <brief_title>Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm
      wavelength laser for the treatment of primary hyperhidrosis of the axilla.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographic evaluation as a measure of improvement</measure>
    <time_frame>up to 6 months post treatment</time_frame>
    <description>2D photography to be taken at various time points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject biopsy sampling</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
    <description>Histological examination of tissue samples pre-treatment and post-treatment as a measure of safety and tolerability</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>HYPERHIDROSIS</condition>
  <arm_group>
    <arm_group_label>Nd:YAG Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nd:YAG 1440nm Laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd:YAG Laser</intervention_name>
    <description>Nd:YAG 1440nm Laser</description>
    <arm_group_label>Nd:YAG Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A healthy non-smoking male or female between 18-56 years of age

          -  Understand/accept obligation not to receive any other procedures in anatomical areas
             exhibiting axillary hyperhidrosis through 3 months prior to treatment

          -  Understand and accept the obligation and is logistically able to present for all
             scheduled follow-up visits

          -  Clinically diagnosed for primary hyperhidrosis of the axilla.

          -  A self assessed HDSS score of three (3) or four (4)

        Exclusion Criteria:

          -  Clinical diagnosis of secondary hyperhidrosis

          -  Uncontrolled systemic disease

          -  Concurrent use of any hyperhidrosis treatments other than OTC antiperspirants or
             deodorants

          -  Receipt of Botox or Dysport within the past six months

          -  Patients who refuse to stop using OTC antiperspirants 24 hours prior to the day of
             surgery and each of the follow-up visits at 3 months and 6 months that Minors starch
             iodine tests may be performed.

          -  Patients using or having used within 7 days of baseline visit: cholinomimetic agents,
             anticholinergic agents, prescription antiperspirants, any herbal medicine treatments
             or any other treatments for hyperhidrosis except OTC antiperspirant or planning to use
             such agents during the course of the study.

          -  Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR
             any other types of treatments for hyperhidrosis in the area to be treated in the past
             6 months or planning to have any treatments for hyperhidrosis or surgery within the
             treatment area during the course of the study.

          -  Allergies to medication or local anesthesia required for the procedure

          -  A history of thrombophlebitis

          -  A history of acute infections

          -  A history of heart failure

          -  Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics,
             vitamin E or anti inflammatories within 2 weeks pre treatment

          -  An intolerance to anesthesia

          -  Any medical condition, that, in the investigator's opinion would interfere with the
             patient's participation in the study

          -  Taking medications that are photosensitive

          -  A history of keloid formation

          -  Is pregnant or has been pregnant in the last 3 months, currently breast feeding or
             planning a pregnancy during the course of the study

          -  Study subjects that can not maintain their pre-study exercise and diet routine over
             the course of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Juva Skin and Laser Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <last_update_submitted>July 29, 2015</last_update_submitted>
  <last_update_submitted_qc>July 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

